Maeda K - Search Results

1

Ogawa C, Tsuchiya K, Maeda K, Nitta K. Ogawa C, et al. Among authors: maeda k. Contrib Nephrol. 2018;195:62-73. doi: 10.1159/000486936. Epub 2018 May 7. Contrib Nephrol. 2018. PMID: 29734151 Review.

2

Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.

Ogawa C, Tsuchiya K, Tomosugi N, Kanda F, Maeda K, Maeda T. Ogawa C, et al. Among authors: maeda k, maeda t. PLoS One. 2017 Jun 29;12(6):e0179608. doi: 10.1371/journal.pone.0179608. eCollection 2017. PLoS One. 2017. PMID: 28662118 Free PMC article.

3

Significance of Content of the Reticulocyte Hemoglobin in the Management of Renal Anemia.

Ogawa C, Tsuchiya K, Nitta K, Maeda K. Ogawa C, et al. Among authors: maeda k. Blood Purif. 2019;47 Suppl 2:70-73. doi: 10.1159/000496641. Epub 2019 Apr 3. Blood Purif. 2019. PMID: 30943480

4

The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study.

Ogawa C, Tsuchiya K, Tomosugi N, Shimada K, Kanda F, Maeda K. Ogawa C, et al. Among authors: maeda k. Hematology. 2020 Dec;25(1):71-78. doi: 10.1080/16078454.2020.1720103. Hematology. 2020. PMID: 32009585

5

Reticulocyte hemoglobin content.

Ogawa C, Tsuchiya K, Maeda K. Ogawa C, et al. Among authors: maeda k. Clin Chim Acta. 2020 May;504:138-145. doi: 10.1016/j.cca.2020.01.032. Epub 2020 Jan 31. Clin Chim Acta. 2020. PMID: 32014518 Review.

6

High serum magnesium levels are associated with favorable prognoses in diabetic hemodialysis patients, retrospective observational study.

Ogawa C, Tsuchiya K, Maeda K. Ogawa C, et al. Among authors: maeda k. PLoS One. 2020 Sep 17;15(9):e0238763. doi: 10.1371/journal.pone.0238763. eCollection 2020. PLoS One. 2020. PMID: 32941454 Free PMC article.

7

A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients.

Ogawa C, Tsuchiya K, Tomosugi N, Maeda K. Ogawa C, et al. Among authors: maeda k. Int J Mol Sci. 2020 Sep 28;21(19):7153. doi: 10.3390/ijms21197153. Int J Mol Sci. 2020. PMID: 32998272 Free PMC article.

8

Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfa.

Ogawa C, Tsuchiya K, Tomosugi N, Maeda K. Ogawa C, et al. Among authors: maeda k. PLoS One. 2021 Jun 18;16(6):e0252439. doi: 10.1371/journal.pone.0252439. eCollection 2021. PLoS One. 2021. PMID: 34143801 Free PMC article.

9

Threshold of Serum Ferritin to Discriminate against Those at Greater Risk of Platelet Increase during Treatment with Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitor.

Ogawa C, Tsuchiya K, Tomosugi N, Maeda K. Ogawa C, et al. Among authors: maeda k. Acta Haematol. 2022;145(4):412-418. doi: 10.1159/000522071. Epub 2022 Jan 20. Acta Haematol. 2022. PMID: 35051929

10

Low-Dose Oral Iron Replacement Therapy Is Effective for Many Japanese Hemodialysis Patients: A Retrospective Observational Study.

Ogawa C, Tsuchiya K, Kanemitsu M, Maeda K. Ogawa C, et al. Among authors: maeda k. Nutrients. 2022 Dec 27;15(1):125. doi: 10.3390/nu15010125. Nutrients. 2022. PMID: 36615783 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,841 results

Search Page